Genetics Generation Advancement Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	4.4yrs

Son yönetim güncellemeleri

Recent updates

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Feb 25

CEO

Genetics Generation Advancement CEO'su yok ya da onlar hakkında elimizde veri yok.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Min Ou	Supervisor	no data	Veri yok	Veri yok
Yu Min Liang	Director	4.4yrs	Veri yok	Veri yok
Cheng-Hsien Tsai	Director	4.4yrs	Veri yok	Veri yok
Ikujin Ko	Independent Director	no data	Veri yok	Veri yok
Yu Chun Hong	Independent Director	no data	Veri yok	Veri yok
Wen Ju Lin	Independent Director	no data	Veri yok	Veri yok
Han Tung Chang	Chairman of the Board	4.4yrs	Veri yok	Veri yok
Wen Cheng Chang	Director	4.4yrs	Veri yok	2.36% NT$ 53.0m

4.4yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: 4160's board of directors are considered experienced (4.4 years average tenure).

Genetics Generation Advancement Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Genetics Generation Advancement Corp., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Genetics Generation Advancement Corp., Annual General Meeting, Jun 10, 2021

Recent updates

Upcoming dividend of NT$0.51 per share

Second quarter 2024 earnings released: EPS: NT$0.72 (vs NT$0.37 in 2Q 2023)

Dividend of NT$0.51 announced

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 29%

Investor sentiment improves as stock rises 23%

First quarter 2024 earnings released: EPS: NT$0.56 (vs NT$0.29 in 1Q 2023)

Investor sentiment improves as stock rises 22%

Genetics Generation Advancement Corp., Annual General Meeting, Jun 18, 2024

Full year 2023 earnings released: EPS: NT$1.12 (vs NT$1.01 in FY 2022)

Third quarter 2023 earnings released: EPS: NT$0.19 (vs NT$0.31 in 3Q 2022)

Upcoming dividend of NT$0.48 per share at 1.1% yield

Second quarter 2023 earnings released: EPS: NT$0.38 (vs NT$0.036 in 2Q 2022)

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.32 (vs NT$0.15 in 3Q 2021)

Upcoming dividend of NT$0.29 per share

Genetics Generation Advancement Corp. Announces Cash Dividend, Payable on September 30, 2022

First quarter 2022 earnings released: EPS: NT$0.44 (vs NT$0.019 loss in 1Q 2021)

Full year 2021 earnings released: EPS: NT$0.32 (vs NT$0.65 loss in FY 2020)

Third quarter 2021 earnings released: EPS NT$0.15 (vs NT$0.19 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.26 (vs NT$0.096 loss in 2Q 2020)

First quarter 2021 earnings released: NT$0.02 loss per share (vs NT$0.01 profit in 1Q 2020)

Full year 2020 earnings released: NT$0.65 loss per share (vs NT$0.76 profit in FY 2019)

Genetics Generation Advancement Corp., Annual General Meeting, Jun 10, 2021

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

New 90-day low: NT$23.05

New 90-day low: NT$23.10

New 90-day high: NT$25.50

New 90-day low: NT$24.00

Third quarter 2020 earnings released: NT$0.19 loss per share

New 90-day low: NT$24.20

New 90-day low - NT$26.20

New 90-day low - NT$26.80

First half earnings released

CEO

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi